Search

Raymond J. Henley Iii

Examiner (ID: 7179, Phone: (571)272-0575 , Office: P/1629 )

Most Active Art Unit
1614
Art Unit(s)
1205, 2899, 1629, 1614, 1621
Total Applications
4324
Issued Applications
3034
Pending Applications
603
Abandoned Applications
710

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11625828 [patent_doc_number] => 20170136014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor and/or a JAK-2 Inhibitor' [patent_app_type] => utility [patent_app_number] => 15/319740 [patent_app_country] => US [patent_app_date] => 2015-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 164 [patent_figures_cnt] => 164 [patent_no_of_words] => 149689 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319740 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/319740
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/or a JAK-2 inhibitor Jun 16, 2015 Issued
Array ( [id] => 11541643 [patent_doc_number] => 20170095468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-06 [patent_title] => 'TRANSDERMAL FORMULATIONS OF PERGOLIDE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/314727 [patent_app_country] => US [patent_app_date] => 2015-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8092 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314727 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/314727
Transdermal formulations of pergolide and uses thereof Jun 10, 2015 Issued
Array ( [id] => 10387955 [patent_doc_number] => 20150272962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'METHODS FOR TREATING OR PREVENTING CANCER AND NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 14/735798 [patent_app_country] => US [patent_app_date] => 2015-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22324 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14735798 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/735798
METHODS FOR TREATING OR PREVENTING CANCER AND NEURODEGENERATIVE DISEASES Jun 9, 2015 Abandoned
Array ( [id] => 10459384 [patent_doc_number] => 20150344398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => '4-HYDROXYBUTYRIC ACID ANALOGS' [patent_app_type] => utility [patent_app_number] => 14/732859 [patent_app_country] => US [patent_app_date] => 2015-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9352 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14732859 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/732859
4-hydroxybutyric acid analogs Jun 7, 2015 Issued
Array ( [id] => 11527133 [patent_doc_number] => 20170087110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-30 [patent_title] => 'Methods of Treating Neurodevelopmental Diseases and Disorders' [patent_app_type] => utility [patent_app_number] => 15/316110 [patent_app_country] => US [patent_app_date] => 2015-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10567 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316110 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/316110
Methods of treating neurodevelopmental diseases and disorders Jun 4, 2015 Issued
Array ( [id] => 10174868 [patent_doc_number] => 09205055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-08 [patent_title] => 'Controlled release hydrocodone formulations' [patent_app_type] => utility [patent_app_number] => 14/727997 [patent_app_country] => US [patent_app_date] => 2015-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12988 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14727997 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/727997
Controlled release hydrocodone formulations Jun 1, 2015 Issued
Array ( [id] => 11742764 [patent_doc_number] => 20170196836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-13 [patent_title] => 'Lung Cancer Adjuvant Therapy' [patent_app_type] => utility [patent_app_number] => 15/313339 [patent_app_country] => US [patent_app_date] => 2015-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11209 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313339 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/313339
Lung cancer adjuvant therapy May 26, 2015 Issued
Array ( [id] => 10365755 [patent_doc_number] => 20150250760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'VITAMIN C AND VITAMIN K, AND COMPOSITIONS THEREOF FOR TREATMENT OF OSTEOLYSIS OR PROLONGATION OF PROSTHETIC IMPLANT' [patent_app_type] => utility [patent_app_number] => 14/716587 [patent_app_country] => US [patent_app_date] => 2015-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24675 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14716587 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/716587
Vitamin C and vitamin K, and compositions thereof for treatment of osteolysis or prolongation of prosthetic implant May 18, 2015 Issued
Array ( [id] => 11668315 [patent_doc_number] => 20170157035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'INTRAVASCULAR DELIVERY OF NANOPARTICLE COMPOSITIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/714131 [patent_app_country] => US [patent_app_date] => 2015-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16547 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14714131 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/714131
Intravascular delivery of nanoparticle compositions and uses thereof May 14, 2015 Issued
Array ( [id] => 10435694 [patent_doc_number] => 20150320706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-12 [patent_title] => 'FORMULATIONS AND METHODS OF TREATING ALZHEIMER\'S DISEASE AND OTHER PROTEINOPATHIES BY COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 14/707033 [patent_app_country] => US [patent_app_date] => 2015-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27351 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707033 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/707033
FORMULATIONS AND METHODS OF TREATING ALZHEIMER'S DISEASE AND OTHER PROTEINOPATHIES BY COMBINATION THERAPY May 7, 2015 Abandoned
Array ( [id] => 11721227 [patent_doc_number] => 09694073 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-04 [patent_title] => 'Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(ADP-ribose) polymerase and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/701321 [patent_app_country] => US [patent_app_date] => 2015-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 12971 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14701321 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/701321
Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(ADP-ribose) polymerase and uses thereof Apr 29, 2015 Issued
Array ( [id] => 10353424 [patent_doc_number] => 20150238430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 14/699719 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3839 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14699719 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/699719
PHARMACEUTICAL COMPOSITION Apr 28, 2015 Abandoned
Array ( [id] => 11479385 [patent_doc_number] => 09585907 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'Methods and compositions for modulating Tau levels' [patent_app_type] => utility [patent_app_number] => 14/697156 [patent_app_country] => US [patent_app_date] => 2015-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 54 [patent_no_of_words] => 30519 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14697156 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/697156
Methods and compositions for modulating Tau levels Apr 26, 2015 Issued
Array ( [id] => 11684060 [patent_doc_number] => 09682092 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-20 [patent_title] => 'Boron-containing small molecules as anti-inflammatory agents' [patent_app_type] => utility [patent_app_number] => 14/688581 [patent_app_country] => US [patent_app_date] => 2015-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 34136 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14688581 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/688581
Boron-containing small molecules as anti-inflammatory agents Apr 15, 2015 Issued
Array ( [id] => 11419836 [patent_doc_number] => 20170027979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'METHOD FOR ASSESSING AND TREATING OR PREVENTING IMPAIRED PLASMA POLAR LIPID LEVELS' [patent_app_type] => utility [patent_app_number] => 15/303592 [patent_app_country] => US [patent_app_date] => 2015-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21104 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15303592 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/303592
Method for assessing and treating or preventing impaired plasma polar lipid levels Apr 13, 2015 Issued
Array ( [id] => 12211060 [patent_doc_number] => 09907852 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-06 [patent_title] => 'Anticancer agent and side-effect-alleviating agent' [patent_app_type] => utility [patent_app_number] => 15/302863 [patent_app_country] => US [patent_app_date] => 2015-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 15100 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15302863 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/302863
Anticancer agent and side-effect-alleviating agent Apr 9, 2015 Issued
Array ( [id] => 11722362 [patent_doc_number] => 09695209 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-04 [patent_title] => 'Synthesis of amphiphilic calixarene glycoside detergents and use of same for extracting and stabilizing native functional membrane proteins' [patent_app_type] => utility [patent_app_number] => 15/303039 [patent_app_country] => US [patent_app_date] => 2015-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 13350 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15303039 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/303039
Synthesis of amphiphilic calixarene glycoside detergents and use of same for extracting and stabilizing native functional membrane proteins Apr 7, 2015 Issued
Array ( [id] => 11656014 [patent_doc_number] => 09668994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-06 [patent_title] => 'Methods and compositions for increasing the anaerobic working capacity in tissues' [patent_app_type] => utility [patent_app_number] => 14/673556 [patent_app_country] => US [patent_app_date] => 2015-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 11747 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14673556 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/673556
Methods and compositions for increasing the anaerobic working capacity in tissues Mar 29, 2015 Issued
Array ( [id] => 10311564 [patent_doc_number] => 20150196567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'ADMINISTRATION OF AN ANTI-OBESITY COMPOUND TO INDIVIDUALS WITH RENAL IMPAIRMENT' [patent_app_type] => utility [patent_app_number] => 14/671151 [patent_app_country] => US [patent_app_date] => 2015-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 109238 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14671151 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/671151
ADMINISTRATION OF AN ANTI-OBESITY COMPOUND TO INDIVIDUALS WITH RENAL IMPAIRMENT Mar 26, 2015 Abandoned
Array ( [id] => 11512874 [patent_doc_number] => 20170079948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-23 [patent_title] => 'COMPOSITIONS AND METHODS TO TREAT NIEMANN-PICK DISEASE' [patent_app_type] => utility [patent_app_number] => 15/126339 [patent_app_country] => US [patent_app_date] => 2015-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5090 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15126339 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/126339
Compositions and methods to treat Niemann-Pick disease Mar 26, 2015 Issued
Menu